I expect MM to brief trial results to Gilead, GSK ...
GlaxoSmithKline HIV study shows 'positive' results
By Carlo Martuscelli
Published: Oct 29, 2018 7:25 a.m. ET
0
Time (EDT)Pfizer Inc.10:0011:0012:001:002:003:00
$42.00$42.25$42.50$42.75$43.00$43.25$43.50
ViiV Healthcare, majority-owned by GlaxoSmithKline PLC (GSK.LN), said a phase 2 trial of a two-drug regimen to treat HIV showed positive results.
The Latte-2 trial is a phase 2 study examining an injectable cabotegravir and rilpivirine administered either every eight or four weeks over the course of 160 weeks. The company said the regimen showed a high-rate of virus response, durability and was tolerated well by patients overall.
ViiV said that at 160 weeks, 90% of patients taking the two-drug combination every eight weeks had suppressed levels of HIV, with the level decreasing to 83% for patients receiving it every four weeks. The treatment failed for two patients whose viral loads exceeded an acceptable threshold.
The HIV-focused drug-development company said a majority of participants developed an inflammation at the injection site. Other common side effects included colds, diarrhea and headaches. ViiV said that 3% and 10% of patients had adverse reactions leading to withdrawal and discontinuation of treatment for the eight-week and four-week regimens respectively.
ViiV Healthcare is majority-owned by Glaxo, with Pfizer Inc. PFE, -1.87% and Shionogi Limited also holding stakes.
- Forums
- ASX - By Stock
- BIT
- Next week's SP
Next week's SP, page-159
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $19.85M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $23.85K | 1.129M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 155000 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 983781 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 155000 | 0.020 |
12 | 2598963 | 0.019 |
10 | 1719636 | 0.018 |
7 | 2103408 | 0.017 |
13 | 1691225 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 983781 | 4 |
0.023 | 1449422 | 4 |
0.024 | 112849 | 1 |
0.025 | 173000 | 2 |
0.027 | 169508 | 3 |
Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online